Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-β/Smad Pathway Activation
暂无分享,去创建一个
Haitao Zhu | Xiaoqing Sun | Ren-fu Chen | Xiaoxiao Jiang | Yaping Chen | Bo Wang | P. Qu
[1] Le Yang,et al. Sodium tanshinone IIA sulfonate attenuates the transforming growth factor-β1-induced differentiation of atrial fibroblasts into myofibroblasts in vitro. , 2015, International journal of molecular medicine.
[2] K. Ishibashi,et al. TGF-β1-siRNA delivery with nanoparticles inhibits peritoneal fibrosis , 2015, Gene Therapy.
[3] M. Costache,et al. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor‐β1 在晚期糖基化终末产物环境中细胞外基质通过RAGE受体依赖性途径调节,转化生长因子‐β1可以促进这种调节 , 2015, Journal of diabetes.
[4] Hao Xu,et al. Anti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for Atherosclerosis , 2014, Evidence-based complementary and alternative medicine : eCAM.
[5] Junfeng Zhang,et al. MicroRNA‐101 suppresses liver fibrosis by targeting the TGFβ signalling pathway , 2014, The Journal of pathology.
[6] H. Yeger,et al. TGF-β1 induces EMT reprogramming of porcine bladder urothelial cells into collagen producing fibroblasts-like cells in a Smad2/Smad3-dependent manner , 2013, Journal of Cell Communication and Signaling.
[7] Juan-juan Ma,et al. Multitargeted inhibition of hepatic fibrosis in chronic iron-overloaded mice by Salvia miltiorrhiza. , 2013, Journal of ethnopharmacology.
[8] Daixing Zhou,et al. Inhibitory effect of tanshinone II A on TGF II-β1-induced cardiac fibrosis , 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[9] V. Tuohy,et al. Connective tissue and its growth factor CTGF distinguish the morphometric and molecular remodeling of the bladder in a model of neurogenic bladder. , 2012, American journal of physiology. Renal physiology.
[10] V. Teixeira,et al. Amitriptyline aggravates the fibrosis process in a rat model of infravesical obstruction , 2012, International journal of experimental pathology.
[11] P. Little,et al. Corrigendum to: cardiovascular actions and therapeutic potential of tanshinone IIA [Atherosclerosis 220 (2012) 3-10] , 2012 .
[12] P. Little,et al. Cardiovascular actions and therapeutic potential of tanshinone IIA. , 2012, Atherosclerosis.
[13] Z. Miao,et al. Tanshinone IIA Attenuates Peritoneal Fibrosis through Inhibition of Fibrogenic Growth Factors Expression in Peritoneum in a Peritoneal Dialysis Rat Model , 2011, Renal failure.
[14] Ping Wang,et al. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[15] G. Ling,et al. Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-β/Smad activity , 2010, Laboratory Investigation.
[16] John C. Thomas,et al. Bladder stromal loss of transforming growth factor receptor II decreases fibrosis after bladder obstruction. , 2009, The Journal of urology.
[17] Le Yang,et al. Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro , 2009, Experimental & Molecular Medicine.
[18] R. Levin,et al. Bladder outlet obstruction accelerates bladder carcinogenesis , 2009, BJU International.
[19] R. Dahiya,et al. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury‐induced neurogenic rat bladder , 2009, BJU international.
[20] B. Shi,et al. Alterations of Urine TGF-β1 and bFGF following Bladder Outlet Obstruction: A Predictor for Detrusor Contractibility? , 2009, Urologia Internationalis.
[21] Jianhua Zhou,et al. Effects of tanshinone IIA on transforming growth factor β1-Smads signal pathway in renal interstitial fibroblasts of rats , 2008, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[22] Shuting Lin,et al. Sodium Tanshinone IIA Sulfonate Protects Mice From ConA-Induced Hepatitis via Inhibiting NF-κB and IFN-γ/STAT1 Pathways , 2008, Journal of Clinical Immunology.
[23] Jianhua Zhou,et al. Effects of tanshinone IIA on transforming growth factor β1-Smads signal pathway in renal interstitial fibroblasts of rats , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].
[24] Y. Tabata,et al. Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. , 2007, American journal of physiology. Renal physiology.
[25] F. Sampaio,et al. Stereological study of collagen and elastic system in the detrusor muscle of bladders from controls and patients with infravesical obstruction. , 2007, International braz j urol : official journal of the Brazilian Society of Urology.
[26] C. Padovani,et al. Structural alterations of the bladder induced by detrusor instability. Experimental study in rabbits. , 2005, International braz j urol : official journal of the Brazilian Society of Urology.
[27] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[28] R. Derynck,et al. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.
[29] M. Goumans,et al. Transforming growth factor β signal transduction , 2002, Journal of leukocyte biology.
[30] H. Schnaper,et al. It’s a Smad World: Regulation of TGF-β Signaling in the Kidney , 2002 .
[31] H. Schnaper,et al. It's a Smad world: regulation of TGF-beta signaling in the kidney. , 2002, Journal of the American Society of Nephrology : JASN.
[32] M. Goumans,et al. Transforming growth factor beta signal transduction. , 2002, Journal of leukocyte biology.
[33] Y. Kaneda,et al. Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction , 2000 .
[34] Y. Kaneda,et al. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. , 2000, Kidney international.
[35] S. Hayward,et al. Epithelial-mesenchymal interactions in the bladder. Implications for bladder augmentation. , 1999, Advances in experimental medicine and biology.
[36] Y. Li,et al. Epithelial-Mesenchymal Interactions in the Bladder , 1999 .
[37] R. Buttyan,et al. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction. , 1997, European urology.
[38] R. Gilmour,et al. Loss of elasticity in dysfunctional bladders: urodynamic and histochemical correlation. , 1994, The Journal of urology.
[39] M. Becich,et al. Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis. , 1991, The Journal of urology.
[40] A. Wein,et al. Effect of bladder outlet obstruction on the morphology, physiology, and pharmacology of the bladder , 1990, The Prostate. Supplement.